A Phase IIIb Double-Blind, Randomised, Placebo-Controlled Study of Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone.
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Idebenone (Primary)
- Indications Friedreich's ataxia
- Focus Therapeutic Use
- Acronyms PROTI
- Sponsors Santhera Pharmaceuticals
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Mar 2011 Additional trial locations (Austria, Germany, Netherlands) identified as reported by ClinicalTrials.gov.